THE RIGHT THERAPY FOR EVERY PATIENT

Renal Care Solutions
Medtronic established the Renal Care Solutions (RCS) business group in late 2015 to focus on solutions for the ever-expanding acute kidney injury (AKI) and end-stage renal disease (ESRD) patient populations.
IMPROVING PATIENT OUTCOMES
We strive to deliver meaningful innovations that offer measurable clinical and economic value to improve outcomes and quality of life for patients affected by renal disease. With a comprehensive range of renal access and therapies aimed to expand access to renal care worldwide, we continue to strive for solutions that address comorbidities in patients with end stage renal disease.
NEXT-GEN HEMODIALYSIS
RCS is developing a next generation chronic hemodialysis machine technology that is intended to help make dialysis more accessible, while lowering the cost of care by being more efficient and using less water.
ACUTE KIDNEY INJURY TREATMENT
Our solution portfolio is expanding with the addition of technologies to help treat acute kidney injury (AKI) patients.
ADDRESSING COMORBIDITIES
Long term we are also looking into other solutions and services that will help manage comorbidities by leveraging the breadth of Medtronic’s overall portfolio.  This is particularly important as the leading causes of kidney disease are hypertension and diabetes ‒ two well established business areas within Medtronic.
Next-Gen Hemodialysis: In development
** In development
* Not available for sale in Canada
** In development
EDUCATIONAL RESOURCES
Medtronic is dedicated to helping improve care for dialysis patients with innovative products and tailored support.

© 2021 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic.™* Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. 04/2021 – CA-RCS-0044-E